Sangui Bio
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 4054, Royal North Shore Hospital,...Website
www.sanguibio.comRevenue
<$5 MillionIndustry
About Sangui Bio
Sangui Bio specializes in developing blood-based proteomic tests for early colorectal cancer detection, utilizing their VeriPro platform. Their flagship product, ColoPro, is designed to detect advanced precancerous polyps from a simple at-home fingerprick blood sample, targeting high-risk patients in need of ongoing surveillance. The company aims to address the unmet need for blood-based alternatives in colorectal cancer screening, particularly for the 25 million Americans who have had polyps removed. Sangui Bio collaborates with gastroenterology practices, clinical research partners, and strategic investors to advance their clinical validation efforts.Explore more
Sangui Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Sangui Bio
Compare insights from companies similar to Sangui Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sangui Bio Tech Stack
A closer look at the technologies used by Sangui Bio
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Sangui Bio
Sign Up For FreeTo access detailed company insights
Sangui Bio specializes in developing blood-based proteomic tests for early colorectal cancer detection, utilizing their VeriPro platform. Their flagship product, ColoPro, is designed to detect advanced precancerous polyps from a simple at-home fingerprick blood sample, targeting high-risk patients in need of ongoing surveillance. The company aims t... Read More
